US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 20.860
  • -0.190-0.90%
Close Dec 10 16:00 ET
  • 21.200
  • +0.340+1.63%
Pre 09:17 ET
1.44BMarket Cap-6.36P/E (TTM)

Bicycle Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3,786.05%-39.83M
-230.89%-44.63M
-52.70%-70.87M
29.59%-60.63M
-56.02%-47.29M
82.54%-1.03M
244.90%34.1M
-75.80%-46.41M
-482.07%-86.11M
-190.46%-30.31M
Net income from continuing operations
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
Depreciation and amortization
28.52%2.17M
-0.30%1.64M
6.49%1.66M
77.45%6.55M
19.34%1.65M
33.70%1.69M
166.61%1.65M
268.96%1.56M
161.82%3.69M
240.54%1.39M
Deferred tax
-145.59%-3.32M
93.02%-110K
63.58%-767K
166.44%3.31M
87.93%-282K
810.06%7.27M
-81.68%-1.58M
-181.55%-2.11M
-198.32%-4.98M
---2.34M
Other non cash items
1,038.46%1.04M
11.46%107K
1.96%104K
136.20%1.04M
809.64%755K
3.41%91K
-29.41%96K
-24.44%102K
-5.56%442K
-31.40%83K
Change In working capital
-97.16%921K
-123.00%-15.72M
-242.38%-54.58M
11,308.18%76.66M
-62.43%-8.13M
93.03%32.39M
3,122.64%68.34M
-80.28%-15.94M
-98.31%672K
-187.13%-5M
-Change in receivables
84.88%-8.3M
-111.80%-7.54M
-254.16%-15.27M
89.41%-1.2M
31.93%-5.88M
-507.14%-54.88M
543.13%63.87M
-141.78%-4.31M
-523.91%-11.35M
-106.26%-8.63M
-Change in prepaid assets
188.99%3.54M
-135.82%-393K
-383.57%-8.39M
-2.57%-2.07M
2,073.50%2.54M
-1,515.30%-3.98M
201.86%1.1M
-29.38%-1.74M
32.08%-2.02M
105.19%117K
-Change in payables and accrued expense
462.69%8.34M
-90.01%1.36M
-120.91%-11.34M
-30.31%10.4M
-89.30%481K
-74.78%1.48M
89.97%13.57M
-97.96%-5.13M
526.75%14.92M
70.86%4.5M
-Change in other current assets
7.25%1.14M
5.45%1.1M
7.53%1.09M
55.15%4.19M
56.66%1.07M
58.04%1.06M
50.79%1.05M
55.23%1.01M
567.82%2.7M
-79.81%683K
-Change in other current liabilities
-21.02%-1.19M
-64.96%-1.13M
-28.15%-1.12M
-148.96%-3.6M
-110.54%-1.06M
-101.84%-985K
-29.17%-682K
-1,297.26%-874K
-1,229.69%-1.45M
79.68%-503K
-Change in other working capital
-102.90%-2.6M
13.63%-9.12M
-299.08%-19.56M
3,329.56%68.95M
-353.43%-5.29M
3,049.42%89.69M
-278.22%-10.55M
-27.27%-4.9M
-105.75%-2.14M
-113.49%-1.17M
Cash from discontinued investing activities
Operating cash flow
-3,786.05%-39.83M
-230.89%-44.63M
-52.70%-70.87M
29.59%-60.63M
-56.02%-47.29M
82.54%-1.03M
244.90%34.1M
-75.80%-46.41M
-482.07%-86.11M
-190.46%-30.31M
Investing cash flow
Cash flow from continuing investing activities
13.35%-435K
-51.62%-420K
99.43%-12K
84.57%-2.93M
96.48%-51K
83.18%-502K
97.17%-277K
55.87%-2.1M
-835.32%-18.99M
-35.71%-1.45M
Net PPE purchase and sale
13.35%-435K
-51.62%-420K
99.43%-12K
84.57%-2.93M
96.48%-51K
83.18%-502K
97.17%-277K
55.87%-2.1M
-835.32%-18.99M
-35.71%-1.45M
Cash from discontinued investing activities
Investing cash flow
13.35%-435K
-51.62%-420K
99.43%-12K
84.57%-2.93M
96.48%-51K
83.18%-502K
97.17%-277K
55.87%-2.1M
-835.32%-18.99M
-35.71%-1.45M
Financing cash flow
Cash flow from continuing financing activities
-113.61%-31.93M
4,371.25%549.61M
-31.16%1.87M
3,636.21%250.03M
-93.44%386K
147,466.67%234.63M
6,203.59%12.29M
504.00%2.72M
-97.91%6.69M
-96.91%5.89M
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
--0
----
Net common stock issuance
-100.42%-979K
4,394.98%545.11M
--0
4,272.17%249.35M
--10K
--234.49M
--12.13M
--2.72M
-98.09%5.7M
----
Proceeds from stock option exercised by employees
556.12%912K
2,627.27%4.5M
93,450.00%1.87M
-31.04%682K
103.24%376K
-12.58%139K
-15.38%165K
-99.56%2K
-86.23%989K
-91.87%185K
Cash from discontinued financing activities
Financing cash flow
-113.61%-31.93M
4,371.25%549.61M
-31.16%1.87M
3,636.21%250.03M
-93.44%386K
147,466.67%234.63M
6,203.59%12.29M
504.00%2.72M
-97.91%6.69M
-96.91%5.89M
Net cash flow
Beginning cash position
182.56%961.91M
55.73%457.54M
55.38%526.97M
-22.69%339.15M
58.42%572.63M
-8.67%340.43M
-27.88%293.82M
-22.69%339.15M
222.58%438.68M
39.28%361.47M
Current changes in cash
-130.97%-72.2M
994.23%504.56M
-50.70%-69.01M
289.49%186.47M
-81.50%-46.95M
2,780.59%233.1M
239.16%46.11M
-49.13%-45.79M
-132.38%-98.41M
-114.44%-25.87M
Effect of exchange rate changes
287.71%1.7M
-137.87%-192K
-191.83%-416K
220.18%1.35M
-63.73%1.29M
65.32%-903K
134.56%507K
175.12%453K
7.51%-1.12M
59,333.33%3.55M
End cash Position
55.67%891.41M
182.56%961.91M
55.73%457.54M
55.38%526.97M
55.38%526.97M
58.42%572.63M
-8.67%340.43M
-27.88%293.82M
-22.69%339.15M
-22.69%339.15M
Free cash flow
-2,537.00%-40.27M
-233.20%-45.05M
-46.12%-70.88M
39.53%-63.56M
-49.07%-47.34M
82.76%-1.53M
201.47%33.82M
-55.70%-48.51M
-524.69%-105.1M
-176.10%-31.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3,786.05%-39.83M-230.89%-44.63M-52.70%-70.87M29.59%-60.63M-56.02%-47.29M82.54%-1.03M244.90%34.1M-75.80%-46.41M-482.07%-86.11M-190.46%-30.31M
Net income from continuing operations -1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M
Depreciation and amortization 28.52%2.17M-0.30%1.64M6.49%1.66M77.45%6.55M19.34%1.65M33.70%1.69M166.61%1.65M268.96%1.56M161.82%3.69M240.54%1.39M
Deferred tax -145.59%-3.32M93.02%-110K63.58%-767K166.44%3.31M87.93%-282K810.06%7.27M-81.68%-1.58M-181.55%-2.11M-198.32%-4.98M---2.34M
Other non cash items 1,038.46%1.04M11.46%107K1.96%104K136.20%1.04M809.64%755K3.41%91K-29.41%96K-24.44%102K-5.56%442K-31.40%83K
Change In working capital -97.16%921K-123.00%-15.72M-242.38%-54.58M11,308.18%76.66M-62.43%-8.13M93.03%32.39M3,122.64%68.34M-80.28%-15.94M-98.31%672K-187.13%-5M
-Change in receivables 84.88%-8.3M-111.80%-7.54M-254.16%-15.27M89.41%-1.2M31.93%-5.88M-507.14%-54.88M543.13%63.87M-141.78%-4.31M-523.91%-11.35M-106.26%-8.63M
-Change in prepaid assets 188.99%3.54M-135.82%-393K-383.57%-8.39M-2.57%-2.07M2,073.50%2.54M-1,515.30%-3.98M201.86%1.1M-29.38%-1.74M32.08%-2.02M105.19%117K
-Change in payables and accrued expense 462.69%8.34M-90.01%1.36M-120.91%-11.34M-30.31%10.4M-89.30%481K-74.78%1.48M89.97%13.57M-97.96%-5.13M526.75%14.92M70.86%4.5M
-Change in other current assets 7.25%1.14M5.45%1.1M7.53%1.09M55.15%4.19M56.66%1.07M58.04%1.06M50.79%1.05M55.23%1.01M567.82%2.7M-79.81%683K
-Change in other current liabilities -21.02%-1.19M-64.96%-1.13M-28.15%-1.12M-148.96%-3.6M-110.54%-1.06M-101.84%-985K-29.17%-682K-1,297.26%-874K-1,229.69%-1.45M79.68%-503K
-Change in other working capital -102.90%-2.6M13.63%-9.12M-299.08%-19.56M3,329.56%68.95M-353.43%-5.29M3,049.42%89.69M-278.22%-10.55M-27.27%-4.9M-105.75%-2.14M-113.49%-1.17M
Cash from discontinued investing activities
Operating cash flow -3,786.05%-39.83M-230.89%-44.63M-52.70%-70.87M29.59%-60.63M-56.02%-47.29M82.54%-1.03M244.90%34.1M-75.80%-46.41M-482.07%-86.11M-190.46%-30.31M
Investing cash flow
Cash flow from continuing investing activities 13.35%-435K-51.62%-420K99.43%-12K84.57%-2.93M96.48%-51K83.18%-502K97.17%-277K55.87%-2.1M-835.32%-18.99M-35.71%-1.45M
Net PPE purchase and sale 13.35%-435K-51.62%-420K99.43%-12K84.57%-2.93M96.48%-51K83.18%-502K97.17%-277K55.87%-2.1M-835.32%-18.99M-35.71%-1.45M
Cash from discontinued investing activities
Investing cash flow 13.35%-435K-51.62%-420K99.43%-12K84.57%-2.93M96.48%-51K83.18%-502K97.17%-277K55.87%-2.1M-835.32%-18.99M-35.71%-1.45M
Financing cash flow
Cash flow from continuing financing activities -113.61%-31.93M4,371.25%549.61M-31.16%1.87M3,636.21%250.03M-93.44%386K147,466.67%234.63M6,203.59%12.29M504.00%2.72M-97.91%6.69M-96.91%5.89M
Net issuance payments of debt --------------0--0--------------0----
Net common stock issuance -100.42%-979K4,394.98%545.11M--04,272.17%249.35M--10K--234.49M--12.13M--2.72M-98.09%5.7M----
Proceeds from stock option exercised by employees 556.12%912K2,627.27%4.5M93,450.00%1.87M-31.04%682K103.24%376K-12.58%139K-15.38%165K-99.56%2K-86.23%989K-91.87%185K
Cash from discontinued financing activities
Financing cash flow -113.61%-31.93M4,371.25%549.61M-31.16%1.87M3,636.21%250.03M-93.44%386K147,466.67%234.63M6,203.59%12.29M504.00%2.72M-97.91%6.69M-96.91%5.89M
Net cash flow
Beginning cash position 182.56%961.91M55.73%457.54M55.38%526.97M-22.69%339.15M58.42%572.63M-8.67%340.43M-27.88%293.82M-22.69%339.15M222.58%438.68M39.28%361.47M
Current changes in cash -130.97%-72.2M994.23%504.56M-50.70%-69.01M289.49%186.47M-81.50%-46.95M2,780.59%233.1M239.16%46.11M-49.13%-45.79M-132.38%-98.41M-114.44%-25.87M
Effect of exchange rate changes 287.71%1.7M-137.87%-192K-191.83%-416K220.18%1.35M-63.73%1.29M65.32%-903K134.56%507K175.12%453K7.51%-1.12M59,333.33%3.55M
End cash Position 55.67%891.41M182.56%961.91M55.73%457.54M55.38%526.97M55.38%526.97M58.42%572.63M-8.67%340.43M-27.88%293.82M-22.69%339.15M-22.69%339.15M
Free cash flow -2,537.00%-40.27M-233.20%-45.05M-46.12%-70.88M39.53%-63.56M-49.07%-47.34M82.76%-1.53M201.47%33.82M-55.70%-48.51M-524.69%-105.1M-176.10%-31.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data